Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Phytera and Novelos Therapeutics enter collaborative agreement for novel cancer immunotherapy

Aug. 18, 2000

Biomira initiates phase IIb trial of BLP25 vaccine

Aug. 11, 2000

Positive interim phase I/II data shown for Multikine in head and neck cancer

Aug. 9, 2000

Allovectin-7 phase I/II data released

Aug. 8, 2000

Beta LT meets safety goals early in clinical trials

Aug. 7, 2000

Trial set to test efficacy of bismuth-213-labeled monoclonal antibody in leukemia patients

Aug. 4, 2000

SciClone's Zadaxin prevents lung tumors in mouse model

Aug. 4, 2000

Clinicians urge review of the cardiotoxicity of trastuzumab

July 31, 2000

VRCTC-310-Onco enhances serum antiinflammatory cytokine production in humans

July 28, 2000

New allogeneic cancer vaccines in development at Onyvax

July 25, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...